Children diagnosed with diabetic ketoacidosis and type 1 diabetes may have higher HbA1C levels.
Diabetes
Latest News
Advertisement
CME Content
Advertisement
Pharmacists’ roles are expanding from traditional retail settings, allowing them to be more involved in patient care than ever before.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Eradicating hepatitis C virus with antiviral drugs found to improve comorbid conditions.
Diabetes' propensity to cause metabolic derangement is directly responsible for a looming epidemic of diabetic kidney disease (DKD). And left unchecked, DKD can progress to end-stage kidney disease (ESKD).
How can we reduce the burden of type 1 diabetes? Automated insulin delivery systems could be the answer.
A diabetes wearable device can measure cortisol, glucose, and interleukin-6 in sweat to track disease progession.
Dutasteride (Avodart) increases blood sugar, A1C, and blood lipids.
Liraglutide is an injectable prescription drug that may improve glucose in adults with type 2 diabetes.
Prebiotics seen to reduce weight gain among pediatric patients who were overweight or obese.
Patients with diabetes could benefit greatly from technological advances.
Approximately 72% of Medicare beneficiaries have at least 2 chronic medical conditions (most often diabetes, heart disease, and asthma/COPD), and roughly 40% have 4 or more.
Top articles of the week from The American Journal of Pharmacy Benefits.
Alternative treatment options to control blood glucose level in patients with type 2 diabetes show promise.
Novel treatment may prevent patients with type 1 diabetes from developing end-stage renal disease.
A dose of insulin 3 hours after eating may prevent blood vessel damage among patients with type 1 diabetes.
Top news of the day from across the health care landscape.
Patients with type 2 diabetes who do not take insulin may not require fingerstick testing.
Top news of the day from across the healthcare landscape.
Type 2 diabetes could result from beta cells becoming immature and not properly functioning.
Adding an investigational diabetes drug to anti-cancer regimen may reduce cardiotoxicity.
Top news of the day from across the health care landscape.
Gray market diagnostic OTC medical devices pose substantial health and safety risks to patients.
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
2
From Mutation to Medicine: Targeted Therapies in Lung Cancer
3
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
4
Addressing Drug Resistance in Lung Cancer
5
